A Comprehensive Supply Chain for Core Intermediates in Diabetes Treatment
End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable.
March 6, 2026
Pyrroloquinoline quinone disodium salt
PQQ disodium salt, pyrroloquinoline quinone sodium salt; pyrroloquinoline quinone disodium salt, pyrroloquinoline benzoquinone sodium
CAS: 122628-50-6
Chemical Formula: C14H4N2Na2O8
MW: 374.17
Availability: R&D; Commercialization
Pyrroloquinoline quinone disodium salt
⬤ CAS No. 122628-50-6
⬤ Packaging type：
20kg barrel；5kg barrel；1kg bag；500g bag
| Name | Pyrroloquinoline quinone disodium salt |
| CAS Number | 122628-50-6 |
| Molecular Formula | C14H4N2Na2O8 |
| Molecular Weight | 374.17 |
| Alias | Methoxatin disodium salt |
| Product Category | Dietary Supplement |
| Main Functions | Supports mitochondrial growth and development, Antioxidant properties, Improves brain health, cardiovascular health, and metabolic functions |
| Purity Specification | 99% |
| Appearance | Red-brown powder |
| Flash Point | 569.8 ºC |
| Solubility in Water | 6.16 mg/mL (16.46 mM) |
| Storage Conditions | 3 years at -20°C, Powder form |
| Storage Conditions | 2-8°C |
| Form | Solid |
| Color | Pink to red |
| Prohibited Use | For human use and treatment |
| Return Policy | Selleck offers a flexible return policy |
| Overview | The scientific name of PQQ is pyrroloquinoline quinone, which is a new cofactor that has the effects of treating heart disease, neurological diseases, protecting the liver, and maintaining mitochondrial function. |
| Uses | Pyrroloquinolin quinone disodium salt (PQQ-2Na) is a sodium salt derivative of pyrroloquinolin quinone (PQQ-2Na), which is the active ingredient of health products currently on the market. It has nerve growth factor induction activity and has a certain effect on Parkinson’s disease, and can prevent immune liver damage. |
| Target | Human Endogenous Metabolite |
| Biological activity | Pyrroloquinolinequinonedisodiumsalt is a redox cofactor, an anionic redox cycle quinone. It was originally isolated from the culture of methylophilic bacteria and is also present in mammalian tissues. Pyrroloquinolinequinonedisodiumsalt is an essential nutrient for mammals and is important for immune function. |
Customer Reviews
Real customer feedback
Alexandra Thompson
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Ethan Lee
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Sophia Chen
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Lucas Rodriguez
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
What's News
Latest news at Tianming
CDMO vs. Direct Manufacturer: Which Model Fits Your API Strategy?
Drawing from on-the-ground experience in China’s top pharma clusters, this guide cuts through the jargon to reveal when to partner for complex innovation and when to buy from the workhorses of mature production.
March 3, 2026
Case Study: Improving Yield & Purity Through Route Optimization
This case study, based on publicly available academic literature and patents, focuses on the application of synthetic route optimization in improving the yield and purity of Active Pharmaceutical Ingredients (APIs).
February 27, 2026
Still Have Questions？
If you still have questions or need more information, our team is here to help. Please don’t hesitate to contact us for personalized assistance.